- Home
- WHWK vs SEVN Comparison
WHWK vs SEVN Comparison
Compare WHWK & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WHWK | SEVN |
|---|---|---|
| Founded | 2007 | 1986 |
| Country | United States | United States |
| Employees | 23 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.4M | 190.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | WHWK | SEVN |
|---|---|---|
| Price | $4.16 | $8.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.50 | ★ $10.50 |
| AVG Volume (30 Days) | ★ 531.1K | 152.2K |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 13.90% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $29,383,000.00 |
| Revenue This Year | N/A | $27.75 |
| Revenue Next Year | N/A | $4.06 |
| P/E Ratio | ★ N/A | $45.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.57 | $7.90 |
| 52 Week High | $5.50 | $12.82 |
Technical Indicators
Market Signals| Indicator | WHWK | SEVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 53.44 |
| Support Level | $3.85 | $8.46 |
| Resistance Level | $4.38 | $8.87 |
| Average True Range (ATR) | 0.35 | 0.24 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 20.27 | 49.47 |
Price Performance
Historical ComparisonAbout WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.